Sentences with phrase «in patients with multiple sclerosis»

A small pilot study indicated that the same communications channels might be used to send messages between the brain and the peripheral immune system in patients with multiple sclerosis.

Is the association between health - related quality of life and fatigue mediated by depression in patients with multiple sclerosis?

Cognitive behaviour therapy administered by telephone for the treatment of depressive symptoms in patients with multiple sclerosis significantly improved adherence to treatment and clinical outcomes.13 Management and follow up care by telephone of people with depression improves outcomes at modest cost.14 w46

This study, «Warmer outdoor temperature is associated with task - related increased BOLD activation in patients with multiple sclerosis,» released by Brain Imaging & Behavior corroborates the group's previous study that established that people with MS performed worse on processing speed and memory tasks during warmer outdoor temperatures versus during cooler outdoor temperatures.

A pilot study has shown that treatment with deep transcranial magnetic stimulation (dTMS) significantly reduces symptoms of fatigue in patients with multiple sclerosis (MS).

With this, the working group at the MedUni Vienna has also achieved a better generalisability of the research results so far with regard to working memory and attention in patients with multiple sclerosis.

«Deep brain stimulation: A new treatment approach in patients with multiple sclerosis.»

«These are exciting findings that... could ultimately result in new therapies to prevent worsening in patients with multiple sclerosis,» says Stephen Waxman, a neurologist at the Yale School of Medicine.

Leaky blood vessels in the brain called cerebral microbleeds are associated with an increased risk of physical and cognitive disability in patients with multiple sclerosis (MS), according to a new study by researchers in the Jacobs School of Medicine and Biomedical Sciences at the University at Buffalo.

A Vanderbilt University Medical Center - led research team has shown that magnetic resonance imaging (MRI) can detect changes in resting - state spinal cord function in patients with multiple sclerosis (MS).

Kessler will conduct a study of a combination therapy using dalfampridine — a drug recently approved to improve walking in patients with multiple sclerosis — with a standardized program of locomotor training, a rehabilitative intervention that has improved walking and other functional outcomes in persons with spinal cord injuries.

Dr. DeLuca, a well - known expert in cognitive rehabilitation research, will discuss the cognitive issues that are often under recognized in patients with multiple sclerosis.

We have found this imaging method to be very useful in patients with multiple sclerosis, and now we are able to use it in patients who have Alzheimer's disease (AD), in order to get a sense of the problems that might be developing in their brain before memory problems occur.

Safety and immunological effects of mesenchymal stem cell transplantation in patients with multiple sclerosis and amyotrophic lateral sclerosis.

Long - term studies have reported hyperthyroidism, hypothyroidism, increased thyroid autoimmunity and Hashimoto's disease in patients with multiple sclerosis who use interferon.

Immune response has also been linked to depression, leading researchers to think it could be a shared pathological mechanism that leads to the increased rates of depressive symptoms in patients with multiple sclerosis.

Neuroscientists at Kessler Foundation have documented increased cerebral activation in patients with multiple sclerosis (MS) following memory retraining using the modified Story Memory Technique (mSMT).

A pilot study conducted by researchers from Charité's NeuroCure Cluster of Excellence has shown that treatment with deep transcranial magnetic stimulation (dTMS) significantly reduces symptoms of fatigue in patients with multiple sclerosis (MS).

New research by King's College London, Imperial College London and Imanova Center for Imaging Sciences, suggests that brain inflammation could lead to increased rates of depressive symptoms in patients with multiple sclerosis.

Ekaterina Dobryakova, Ph D., a postdoctoral fellow in Kessler Foundation Neuropsychology and Neuroscience Research received a competitive research award from the New Jersey Neuropsychological Society to study whether motivation influences cognitive fatigue and the brain regions associated with it in patients with multiple sclerosis (MS).